{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:37:19Z","timestamp":1792784239748,"version":"4.5.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003448","name":"General Secretariat for Research and Innovation","doi-asserted-by":"publisher","award":["MIS 5049385"],"award-info":[{"award-number":["MIS 5049385"]}],"id":[{"id":"10.13039\/501100003448","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003448","name":"General Secretariat for Research and Innovation","doi-asserted-by":"publisher","award":["MIS 5049385"],"award-info":[{"award-number":["MIS 5049385"]}],"id":[{"id":"10.13039\/501100003448","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003448","name":"General Secretariat for Research and Innovation","doi-asserted-by":"publisher","award":["MIS 5049385"],"award-info":[{"award-number":["MIS 5049385"]}],"id":[{"id":"10.13039\/501100003448","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Academy of Athens","id":[{"id":"https:\/\/ror.org\/00qsdn986","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Diagnosing atypical parkinsonian syndromes (APS) remains challenging due to overlapping clinical features and limited diagnostic tools. Brain-enriched microRNAs (miRNAs), which regulate neuronal development and function, are detectable in plasma and could serve as molecular biomarkers. This prospective study aimed to identify plasma brain-enriched miRNAs that can distinguish APS and elucidate affected molecular pathways. Reverse transcription-quantitative PCR (RT-qPCR) was performed on plasma samples from patients with idiopathic Parkinson\u2019s disease (iPD), multiple system atrophy (MSA), including the cerebellar subtype (MSA-C) and the parkinsonian subtype (MSA-P), progressive supranuclear palsy (PSP), and healthy controls. MiRNA expression analysis revealed distinct molecular fingerprints for each parkinsonian syndrome, with opposite trends between MSA and iPD compared to controls, suggesting distinct pathogenic mechanisms. Most dysregulated miRNAs clustered at chromosome (Chr)14q32 and shared binding sites for CREB1, CEBPB, and MAZ transcription factors. Pathway analysis revealed enrichment in prion diseases, Hippo signaling, TGF-beta signaling, and FoxO signaling pathways.<\/jats:p>","DOI":"10.1007\/s12035-025-04890-w","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T11:53:14Z","timestamp":1743853994000},"page":"10118-10132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Plasma miRNA Biomarker Signatures in Parkinsonian Syndromes"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8347-218X","authenticated-orcid":false,"given":"Stylianos","family":"Ravanidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3006-8711","authenticated-orcid":false,"given":"Anastasia","family":"Bougea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5806-0717","authenticated-orcid":false,"given":"Christos","family":"Koros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7130-6256","authenticated-orcid":false,"given":"Athina-Maria","family":"Simitsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3311-0049","authenticated-orcid":false,"given":"Panagiotis","family":"Kokotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3569-8990","authenticated-orcid":false,"given":"Leonidas","family":"Stefanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1305-0739","authenticated-orcid":false,"given":"Epaminondas","family":"Doxakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"issue":"Suppl 1","key":"4890_CR1","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/jnc.13691","volume":"139","author":"S Sveinbjornsdottir","year":"2016","unstructured":"Sveinbjornsdottir S (2016) The clinical symptoms of Parkinson\u2019s disease. J Neurochem 139(Suppl 1):318\u2013324. https:\/\/doi.org\/10.1111\/jnc.13691","journal-title":"J Neurochem"},{"issue":"9192","key":"4890_CR2","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/s0140-6736(99)04137-9","volume":"354","author":"A Schrag","year":"1999","unstructured":"Schrag A, Ben-Shlomo Y, Quinn NP (1999) Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 354(9192):1771\u20131775. https:\/\/doi.org\/10.1016\/s0140-6736(99)04137-9","journal-title":"Lancet"},{"issue":"2","key":"4890_CR3","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1212\/wnl.48.2.384","volume":"48","author":"Y Ben-Shlomo","year":"1997","unstructured":"Ben-Shlomo Y, Wenning GK, Tison F, Quinn NP (1997) Survival of patients with pathologically proven multiple system atrophy: a meta-analysis. Neurology 48(2):384\u2013393. https:\/\/doi.org\/10.1212\/wnl.48.2.384","journal-title":"Neurology"},{"issue":"Pt 6","key":"4890_CR4","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1093\/brain\/awm032","volume":"130","author":"LI Golbe","year":"2007","unstructured":"Golbe LI, Ohman-Strickland PA (2007) A clinical rating scale for progressive supranuclear palsy. Brain 130(Pt 6):1552\u20131565. https:\/\/doi.org\/10.1093\/brain\/awm032","journal-title":"Brain"},{"issue":"3","key":"4890_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181\u2013184. https:\/\/doi.org\/10.1136\/jnnp.55.3.181","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"4890_CR6","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1001\/jamaneurol.2021.1312","volume":"78","author":"T Mitchell","year":"2021","unstructured":"Mitchell T, Lehericy S, Chiu SY, Strafella AP, Stoessl AJ, Vaillancourt DE (2021) Emerging neuroimaging biomarkers across disease stage in Parkinson disease: a review. JAMA Neurol 78(10):1262\u20131272. https:\/\/doi.org\/10.1001\/jamaneurol.2021.1312","journal-title":"JAMA Neurol"},{"issue":"11","key":"4890_CR7","doi-asserted-by":"publisher","first-page":"e01808","DOI":"10.1002\/brb3.1808","volume":"10","author":"CH Park","year":"2020","unstructured":"Park CH, Lee PH, Lee SK, Chung SJ, Shin NY (2020) The diagnostic potential of multimodal neuroimaging measures in Parkinson\u2019s disease and atypical parkinsonism. Brain Behav 10(11):e01808. https:\/\/doi.org\/10.1002\/brb3.1808","journal-title":"Brain Behav"},{"issue":"1","key":"4890_CR8","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1038\/s41598-022-06663-0","volume":"12","author":"PE Papathoma","year":"2022","unstructured":"Papathoma PE, Markaki I, Tang C, Lilja Lindstrom M, Savitcheva I, Eidelberg D, Svenningsson P (2022) A replication study, systematic review and meta-analysis of automated image-based diagnosis in parkinsonism. Sci Rep 12(1):2763. https:\/\/doi.org\/10.1038\/s41598-022-06663-0","journal-title":"Sci Rep"},{"issue":"4","key":"4890_CR9","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/s41596-022-00787-3","volume":"18","author":"L Concha-Marambio","year":"2023","unstructured":"Concha-Marambio L, Pritzkow S, Shahnawaz M, Farris CM, Soto C (2023) Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid. Nat Protoc 18(4):1179\u20131196. https:\/\/doi.org\/10.1038\/s41596-022-00787-3","journal-title":"Nat Protoc"},{"key":"4890_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.parkreldis.2022.10.007","volume":"104","author":"D Yoo","year":"2022","unstructured":"Yoo D, Bang JI, Ahn C, Nyaga VN, Kim YE, Kang MJ, Ahn TB (2022) Diagnostic value of alpha-synuclein seeding amplification assays in alpha-synucleinopathies: a systematic review and meta-analysis. Parkinsonism Relat Disord 104:99\u2013109. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.10.007","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"4890_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/mds.1062","volume":"16","author":"B Holmberg","year":"2001","unstructured":"Holmberg B, Kallio M, Johnels B, Elam M (2001) Cardiovascular reflex testing contributes to clinical evaluation and differential diagnosis of Parkinsonian syndromes. Move Disord 16(2):217\u2013225. https:\/\/doi.org\/10.1002\/mds.1062","journal-title":"Move Disord"},{"issue":"2","key":"4890_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.5603\/pjnns.96939","volume":"58","author":"JJ Malkiewicz","year":"2024","unstructured":"Malkiewicz JJ, Siuda J (2024) Comparison of autonomic dysfunction in patients with Parkinson\u2019s disease, progressive supranuclear palsy, and multiple system atrophy. Neurol Neurochir Pol 58(2):193\u2013202. https:\/\/doi.org\/10.5603\/pjnns.96939","journal-title":"Neurol Neurochir Pol"},{"issue":"1","key":"4890_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.74.1.56","volume":"74","author":"DE Riley","year":"2003","unstructured":"Riley DE, Chelimsky TC (2003) Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 74(1):56\u201360. https:\/\/doi.org\/10.1136\/jnnp.74.1.56","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"15","key":"4890_CR14","doi-asserted-by":"publisher","first-page":"e1529","DOI":"10.1212\/WNL.0000000000206772","volume":"100","author":"C Gibbons","year":"2023","unstructured":"Gibbons C, Wang N, Rajan S, Kern D, Palma JA, Kaufmann H, Freeman R (2023) Cutaneous alpha-synuclein signatures in patients with multiple system atrophy and Parkinson disease. Neurology 100(15):e1529\u2013e1539. https:\/\/doi.org\/10.1212\/WNL.0000000000206772","journal-title":"Neurology"},{"issue":"15","key":"4890_CR15","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1001\/jama.2024.0792","volume":"331","author":"CH Gibbons","year":"2024","unstructured":"Gibbons CH, Levine T, Adler C, Bellaire B, Wang N, Stohl J, Agarwal P, Aldridge GM et al (2024) Skin biopsy detection of phosphorylated alpha-synuclein in patients with synucleinopathies. JAMA 331(15):1298\u20131306. https:\/\/doi.org\/10.1001\/jama.2024.0792","journal-title":"JAMA"},{"issue":"5","key":"4890_CR16","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00401-023-02557-1","volume":"145","author":"S Dutta","year":"2023","unstructured":"Dutta S, Hornung S, Taha HB, Bitan G (2023) Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges. Acta Neuropathol 145(5):515\u2013540. https:\/\/doi.org\/10.1007\/s00401-023-02557-1","journal-title":"Acta Neuropathol"},{"issue":"4","key":"4890_CR17","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1007\/s00415-023-12093-3","volume":"271","author":"HB Taha","year":"2024","unstructured":"Taha HB, Bogoniewski A (2024) Analysis of biomarkers in speculative CNS-enriched extracellular vesicles for parkinsonian disorders: a comprehensive systematic review and diagnostic meta-analysis. J Neurol 271(4):1680\u20131706. https:\/\/doi.org\/10.1007\/s00415-023-12093-3","journal-title":"J Neurol"},{"issue":"8","key":"4890_CR18","doi-asserted-by":"publisher","first-page":"16280","DOI":"10.3390\/ijms140816280","volume":"14","author":"E Doxakis","year":"2013","unstructured":"Doxakis E (2013) Principles of miRNA-target regulation in metazoan models. Int J Mol Sci 14(8):16280\u201316302. https:\/\/doi.org\/10.3390\/ijms140816280","journal-title":"Int J Mol Sci"},{"issue":"D1","key":"4890_CR19","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","volume":"47","author":"A Kozomara","year":"2019","unstructured":"Kozomara A, Birgaoanu M, Griffiths-Jones S (2019) miRBase: from microRNA sequences to function. Nucleic Acids Res 47(D1):D155\u2013D162. https:\/\/doi.org\/10.1093\/nar\/gky1141","journal-title":"Nucleic Acids Res"},{"issue":"17","key":"4890_CR20","doi-asserted-by":"publisher","first-page":"12726","DOI":"10.1074\/jbc.M109.086827","volume":"285","author":"E Doxakis","year":"2010","unstructured":"Doxakis E (2010) Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. J Biol Chem 285(17):12726\u201312734. https:\/\/doi.org\/10.1074\/jbc.M109.086827","journal-title":"J Biol Chem"},{"issue":"1","key":"4890_CR21","doi-asserted-by":"publisher","first-page":"12702","DOI":"10.1038\/s41598-017-12973-5","volume":"7","author":"L Straniero","year":"2017","unstructured":"Straniero L, Rimoldi V, Samarani M, Goldwurm S, Difonzo A, Kruger R, Deleidi M, Aureli M et al (2017) The GBAP1 pseudogene acts as a ceRNA for the glucocerebrosidase gene GBA by sponging miR-22-3p. Sci Rep 7(1):12702","journal-title":"Sci Rep"},{"issue":"7","key":"4890_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00018-022-04398-9","volume":"79","author":"M Paschou","year":"2022","unstructured":"Paschou M, Papazafiri P, Charalampous C, Zachariadis M, Dedos SG, Doxakis E (2022) Neuronal microRNAs safeguard ER Ca(2+) homeostasis and attenuate the unfolded protein response upon stress. Cell Mol Life Sci 79(7):373. https:\/\/doi.org\/10.1007\/s00018-022-04398-9","journal-title":"Cell Mol Life Sci"},{"key":"4890_CR23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fnagi.2016.00036","volume":"8","author":"AG Hoss","year":"2016","unstructured":"Hoss AG, Labadorf A, Beach TG, Latourelle JC, Myers RH (2016) microRNA profiles in Parkinson\u2019s disease prefrontal cortex. Front Aging Neurosci 8:36. https:\/\/doi.org\/10.3389\/fnagi.2016.00036","journal-title":"Front Aging Neurosci"},{"key":"4890_CR24","doi-asserted-by":"publisher","first-page":"101023","DOI":"10.1016\/j.arr.2020.101023","volume":"58","author":"E Doxakis","year":"2020","unstructured":"Doxakis E (2020) Cell-free microRNAs in Parkinson\u2019s disease: potential biomarkers that provide new insights into disease pathogenesis. Ageing Res Rev 58:101023. https:\/\/doi.org\/10.1016\/j.arr.2020.101023","journal-title":"Ageing Res Rev"},{"issue":"1","key":"4890_CR25","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3892\/mmr.2017.7995","volume":"17","author":"K Kume","year":"2018","unstructured":"Kume K, Iwama H, Deguchi K, Ikeda K, Takata T, Kokudo Y, Kamada M, Fujikawa K et al (2018) Serum microRNA expression profiling in patients with multiple system atrophy. Mol Med Rep 17(1):852\u2013860. https:\/\/doi.org\/10.3892\/mmr.2017.7995","journal-title":"Mol Med Rep"},{"key":"4890_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.parkreldis.2021.11.020","volume":"93","author":"I Manna","year":"2021","unstructured":"Manna I, Quattrone A, De Benedittis S, Vescio B, Iaccino E, Quattrone A (2021) Exosomal miRNA as peripheral biomarkers in Parkinson\u2019s disease and progressive supranuclear palsy: a pilot study. Parkinsonism Relat Disord 93:77\u201384. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.11.020","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"4890_CR27","doi-asserted-by":"publisher","first-page":"7736","DOI":"10.1007\/s12035-016-0253-0","volume":"54","author":"TM Marques","year":"2017","unstructured":"Marques TM, Kuiperij HB, Bruinsma IB, van Rumund A, Aerts MB, Esselink RAJ, Bloem BR, Verbeek MM (2017) MicroRNAs in cerebrospinal fluid as potential biomarkers for Parkinson\u2019s disease and multiple system atrophy. Mol Neurobiol 54(10):7736\u20137745. https:\/\/doi.org\/10.1007\/s12035-016-0253-0","journal-title":"Mol Neurobiol"},{"issue":"10","key":"4890_CR28","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1002\/mds.28143","volume":"35","author":"A Perez-Soriano","year":"2020","unstructured":"Perez-Soriano A, Bravo P, Soto M, Infante J, Fernandez M, Valldeoriola F, Munoz E, Compta Y et al (2020) MicroRNA deregulation in blood serum identifies multiple system atrophy altered pathways. Move Disord 35(10):1873\u20131879. https:\/\/doi.org\/10.1002\/mds.28143","journal-title":"Move Disord"},{"key":"4890_CR29","doi-asserted-by":"publisher","unstructured":"Ramaswamy P, Christopher R, Kumar Pal P, Debnath M, Yadav R (2022) Plasma microRNAs as a potential biomarker for identification of progressive supranuclear palsy. Diagnostics 12 (5). https:\/\/doi.org\/10.3390\/diagnostics12051204","DOI":"10.3390\/diagnostics12051204"},{"issue":"2","key":"4890_CR30","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/mds.27542","volume":"34","author":"C Starhof","year":"2019","unstructured":"Starhof C, Hejl AM, Heegaard NHH, Carlsen AL, Burton M, Lilje B, Winge K (2019) The biomarker potential of cell-free microRNA from cerebrospinal fluid in parkinsonian syndromes. Move Disord 34(2):246\u2013254. https:\/\/doi.org\/10.1002\/mds.27542","journal-title":"Move Disord"},{"issue":"1","key":"4890_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13041-019-0471-2","volume":"12","author":"H Uwatoko","year":"2019","unstructured":"Uwatoko H, Hama Y, Iwata IT, Shirai S, Matsushima M, Yabe I, Utsumi J, Sasaki H (2019) Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson\u2019s disease. Mol Brain 12(1):49. https:\/\/doi.org\/10.1186\/s13041-019-0471-2","journal-title":"Mol Brain"},{"issue":"6","key":"4890_CR32","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU Hoglinger","year":"2017","unstructured":"Hoglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Muller U et al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Move Disord 32(6):853\u2013864. https:\/\/doi.org\/10.1002\/mds.26987","journal-title":"Move Disord"},{"issue":"6","key":"4890_CR33","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/mds.29005","volume":"37","author":"GK Wenning","year":"2022","unstructured":"Wenning GK, Stankovic I, Vignatelli L, Fanciulli A, Calandra-Buonaura G, Seppi K, Palma JA, Meissner WG et al (2022) The movement disorder society criteria for the diagnosis of multiple system atrophy. Move Disord 37(6):1131\u20131148. https:\/\/doi.org\/10.1002\/mds.29005","journal-title":"Move Disord"},{"issue":"12","key":"4890_CR34","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Move Disord 30(12):1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Move Disord"},{"issue":"1","key":"4890_CR35","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/s41598-019-38505-x","volume":"9","author":"M Faraldi","year":"2019","unstructured":"Faraldi M, Gomarasca M, Sansoni V, Perego S, Banfi G, Lombardi G (2019) Normalization strategies differently affect circulating miRNA profile associated with the training status. Sci Rep 9(1):1584. https:\/\/doi.org\/10.1038\/s41598-019-38505-x","journal-title":"Sci Rep"},{"issue":"12","key":"4890_CR36","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1080\/15476286.2017.1367888","volume":"14","author":"A Keller","year":"2017","unstructured":"Keller A, Rounge T, Backes C, Ludwig N, Gislefoss R, Leidinger P, Langseth H, Meese E (2017) Sources to variability in circulating human miRNA signatures. RNA Biol 14(12):1791\u20131798. https:\/\/doi.org\/10.1080\/15476286.2017.1367888","journal-title":"RNA Biol"},{"issue":"9","key":"4890_CR37","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1002\/acn3.51146","volume":"7","author":"S Ravanidis","year":"2020","unstructured":"Ravanidis S, Bougea A, Papagiannakis N, Koros C, Simitsi AM, Pachi I, Breza M, Stefanis L et al (2020) Validation of differentially expressed brain-enriched microRNAs in the plasma of PD patients. Ann Clin Transl Neurol 7(9):1594\u20131607. https:\/\/doi.org\/10.1002\/acn3.51146","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"4890_CR38","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/mds.27928","volume":"35","author":"S Ravanidis","year":"2020","unstructured":"Ravanidis S, Bougea A, Papagiannakis N, Maniati M, Koros C, Simitsi AM, Bozi M, Pachi I et al (2020) Circulating brain-enriched MicroRNAs for detection and discrimination of idiopathic and genetic Parkinson\u2019s disease. Move Disord 35(3):457\u2013467. https:\/\/doi.org\/10.1002\/mds.27928","journal-title":"Move Disord"},{"issue":"1","key":"4890_CR39","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ymeth.2012.09.015","volume":"59","author":"T Blondal","year":"2013","unstructured":"Blondal T, Jensby Nielsen S, Baker A, Andreasen D, Mouritzen P, Wrang Teilum M, Dahlsveen IK (2013) Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods 59(1):S1-6. https:\/\/doi.org\/10.1016\/j.ymeth.2012.09.015","journal-title":"Methods"},{"issue":"4","key":"4890_CR40","doi-asserted-by":"publisher","first-page":"e0153200","DOI":"10.1371\/journal.pone.0153200","volume":"11","author":"JS Shah","year":"2016","unstructured":"Shah JS, Soon PS, Marsh DJ (2016) Comparison of methodologies to detect low levels of hemolysis in serum for accurate assessment of serum microRNAs. PLoS ONE 11(4):e0153200. https:\/\/doi.org\/10.1371\/journal.pone.0153200","journal-title":"PLoS ONE"},{"issue":"11","key":"4890_CR41","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1080\/15476286.2016.1234658","volume":"13","author":"T Fehlmann","year":"2016","unstructured":"Fehlmann T, Ludwig N, Backes C, Meese E, Keller A (2016) Distribution of microRNA biomarker candidates in solid tissues and body fluids. RNA Biol 13(11):1084\u20131088. https:\/\/doi.org\/10.1080\/15476286.2016.1234658","journal-title":"RNA Biol"},{"key":"4890_CR42","doi-asserted-by":"publisher","first-page":"5150","DOI":"10.1038\/srep05150","volume":"4","author":"Z Guo","year":"2014","unstructured":"Guo Z, Maki M, Ding R, Yang Y, Zhang B, Xiong L (2014) Genome-wide survey of tissue-specific microRNA and transcription factor regulatory networks in 12 tissues. Sci Rep 4:5150. https:\/\/doi.org\/10.1038\/srep05150","journal-title":"Sci Rep"},{"issue":"12","key":"4890_CR43","doi-asserted-by":"publisher","first-page":"5127","DOI":"10.1523\/JNEUROSCI.0600-12.2013","volume":"33","author":"A Jovicic","year":"2013","unstructured":"Jovicic A, Roshan R, Moisoi N, Pradervand S, Moser R, Pillai B, Luthi-Carter R (2013) Comprehensive expression analyses of neural cell-type-specific miRNAs identify new determinants of the specification and maintenance of neuronal phenotypes. J Neurosci 33(12):5127\u20135137. https:\/\/doi.org\/10.1523\/JNEUROSCI.0600-12.2013","journal-title":"J Neurosci"},{"issue":"8","key":"4890_CR44","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1093\/nar\/gkw116","volume":"44","author":"N Ludwig","year":"2016","unstructured":"Ludwig N, Leidinger P, Becker K, Backes C, Fehlmann T, Pallasch C, Rheinheimer S, Meder B et al (2016) Distribution of miRNA expression across human tissues. Nucl Acids Res 44(8):3865\u20133877. https:\/\/doi.org\/10.1093\/nar\/gkw116","journal-title":"Nucl Acids Res"},{"issue":"1","key":"4890_CR45","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1756-0381-6-18","volume":"6","author":"D Wolfe","year":"2013","unstructured":"Wolfe D, Dudek S, Ritchie MD, Pendergrass SA (2013) Visualizing genomic information across chromosomes with PhenoGram. BioData mining 6(1):18. https:\/\/doi.org\/10.1186\/1756-0381-6-18","journal-title":"BioData mining"},{"issue":"D1","key":"4890_CR46","doi-asserted-by":"publisher","first-page":"D253","DOI":"10.1093\/nar\/gky1023","volume":"47","author":"Z Tong","year":"2019","unstructured":"Tong Z, Cui Q, Wang J, Zhou Y (2019) TransmiR v2.0: an updated transcription factor-microRNA regulation database. Nucl Acids Res 47(D1):D253\u2013D258. https:\/\/doi.org\/10.1093\/nar\/gky1023","journal-title":"Nucl Acids Res"},{"issue":"W1","key":"4890_CR47","doi-asserted-by":"publisher","first-page":"W460","DOI":"10.1093\/nar\/gkv403","volume":"43","author":"IS Vlachos","year":"2015","unstructured":"Vlachos IS, Zagganas K, Paraskevopoulou MD, Georgakilas G, Karagkouni D, Vergoulis T, Dalamagas T, Hatzigeorgiou AG (2015) DIANA-miRPath v30: deciphering microRNA function with experimental support. Nucl Acids Res 43(W1):W460-466. https:\/\/doi.org\/10.1093\/nar\/gkv403","journal-title":"Nucl Acids Res"},{"issue":"3","key":"4890_CR48","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44(3):837\u2013845","journal-title":"Biometrics"},{"issue":"30","key":"4890_CR49","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J et al (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105(30):10513\u201310518. https:\/\/doi.org\/10.1073\/pnas.0804549105","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7\u20138","key":"4890_CR50","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41417-018-0067-5","volume":"26","author":"Y Zhong","year":"2019","unstructured":"Zhong Y, Yu C, Qin W (2019) LncRNA SNHG14 promotes inflammatory response induced by cerebral ischemia\/reperfusion injury through regulating miR-136-5p \/ROCK1. Cancer Gene Ther 26(7\u20138):234\u2013247. https:\/\/doi.org\/10.1038\/s41417-018-0067-5","journal-title":"Cancer Gene Ther"},{"issue":"2","key":"4890_CR51","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/s41418-019-0388-4","volume":"27","author":"J Qiao","year":"2020","unstructured":"Qiao J, Zhao J, Chang S, Sun Q, Liu N, Dong J, Chen Y, Yang D et al (2020) MicroRNA-153 improves the neurogenesis of neural stem cells and enhances the cognitive ability of aged mice through the notch signaling pathway. Cell Death Different 27(2):808\u2013825. https:\/\/doi.org\/10.1038\/s41418-019-0388-4","journal-title":"Cell Death Different"},{"issue":"37","key":"4890_CR52","doi-asserted-by":"publisher","first-page":"31298","DOI":"10.1074\/jbc.M112.366336","volume":"287","author":"JM Long","year":"2012","unstructured":"Long JM, Ray B, Lahiri DK (2012) MicroRNA-153 physiologically inhibits expression of amyloid-beta precursor protein in cultured human fetal brain cells and is dysregulated in a subset of Alzheimer disease patients. J Biol Chem 287(37):31298\u201331310. https:\/\/doi.org\/10.1074\/jbc.M112.366336","journal-title":"J Biol Chem"},{"issue":"2","key":"4890_CR53","doi-asserted-by":"publisher","first-page":"e57080","DOI":"10.1371\/journal.pone.0057080","volume":"8","author":"C Wei","year":"2013","unstructured":"Wei C, Thatcher EJ, Olena AF, Cha DJ, Perdigoto AL, Marshall AF, Carter BD, Broadie K et al (2013) miR-153 regulates SNAP-25, synaptic transmission, and neuronal development. PloS one 8(2):e57080. https:\/\/doi.org\/10.1371\/journal.pone.0057080","journal-title":"PloS one"},{"issue":"1","key":"4890_CR54","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3892\/mmr.2019.10829","volume":"21","author":"J Wu","year":"2020","unstructured":"Wu J, Wang C, Ding H (2020) LncRNA MALAT1 promotes neuropathic pain progression through the miR-154-5p\/AQP9 axis in CCI rat models. Mol Med Rep 21(1):291\u2013303. https:\/\/doi.org\/10.3892\/mmr.2019.10829","journal-title":"Mol Med Rep"},{"issue":"5","key":"4890_CR55","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.neuron.2010.01.027","volume":"65","author":"JC Dugas","year":"2010","unstructured":"Dugas JC, Cuellar TL, Scholze A, Ason B, Ibrahim A, Emery B, Zamanian JL, Foo LC et al (2010) Dicer1 and miR-219 are required for normal oligodendrocyte differentiation and myelination. Neuron 65(5):597\u2013611. https:\/\/doi.org\/10.1016\/j.neuron.2010.01.027","journal-title":"Neuron"},{"issue":"12","key":"4890_CR56","doi-asserted-by":"publisher","first-page":"925","DOI":"10.18632\/aging.100624","volume":"5","author":"KS Sheinerman","year":"2013","unstructured":"Sheinerman KS, Tsivinsky VG, Abdullah L, Crawford F, Umansky SR (2013) Plasma microRNA biomarkers for detection of mild cognitive impairment: biomarker validation study. Aging 5(12):925\u2013938. https:\/\/doi.org\/10.18632\/aging.100624","journal-title":"Aging"},{"key":"4890_CR57","doi-asserted-by":"publisher","unstructured":"Inouye MO, Colameo D, Ammann I, Winterer J, Schratt G (2022) miR-329- and miR-495-mediated Prr7 down-regulation is required for homeostatic synaptic depression in rat hippocampal neurons. Life Sci Alliance 5 (12). https:\/\/doi.org\/10.26508\/lsa.202201520","DOI":"10.26508\/lsa.202201520"},{"key":"4890_CR58","doi-asserted-by":"publisher","unstructured":"Puig-Parnau I, Garcia-Brito S, Faghihi N, Gubern C, Aldavert-Vera L, Segura-Torres P, Huguet G, Kadar E (2020) Intracranial self-stimulation modulates levels of SIRT1 protein and neural plasticity-related microRNAs. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-020-01901-w","DOI":"10.1007\/s12035-020-01901-w"},{"issue":"4","key":"4890_CR59","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/cbin.11523","volume":"45","author":"Y Feng","year":"2021","unstructured":"Feng Y, Li T, Xing C, Wang C, Duan Y, Yuan L, Zhang Y (2021) Effective inhibition of miR-330\/SHIP1\/NF-kappaB signaling pathway via miR-330 sponge repolarizes microglia differentiation. Cell Biol Int 45(4):785\u2013794. https:\/\/doi.org\/10.1002\/cbin.11523","journal-title":"Cell Biol Int"},{"issue":"9","key":"4890_CR60","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1002\/emmm.201201900","volume":"5","author":"J Li","year":"2013","unstructured":"Li J, Li J, Liu X, Qin S, Guan Y, Liu Y, Cheng Y, Chen X et al (2013) MicroRNA expression profile and functional analysis reveal that miR-382 is a critical novel gene of alcohol addiction. EMBO Mol Med 5(9):1402\u20131414. https:\/\/doi.org\/10.1002\/emmm.201201900","journal-title":"EMBO Mol Med"},{"issue":"1","key":"4890_CR61","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/glia.23530","volume":"67","author":"X Liu","year":"2019","unstructured":"Liu X, Zhou F, Yang Y, Wang W, Niu L, Zuo D, Li X, Hua H et al (2019) MiR-409-3p and MiR-1896 co-operatively participate in IL-17-induced inflammatory cytokine production in astrocytes and pathogenesis of EAE mice via targeting SOCS3\/STAT3 signaling. Glia 67(1):101\u2013112. https:\/\/doi.org\/10.1002\/glia.23530","journal-title":"Glia"},{"issue":"5","key":"4890_CR62","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1080\/00207454.2021.1938037","volume":"133","author":"H Wang","year":"2023","unstructured":"Wang H, Gao H (2023) Protective effects of repetitive transcranial magnetic stimulation against 6-OHDA-induced Parkinson\u2019s symptoms in a mice model: the key role of miR-409-3p\/PDHB axis. Int J Neurosci 133(5):578\u2013585. https:\/\/doi.org\/10.1080\/00207454.2021.1938037","journal-title":"Int J Neurosci"},{"issue":"22","key":"4890_CR63","doi-asserted-by":"publisher","first-page":"36553","DOI":"10.18632\/oncotarget.16615","volume":"8","author":"DX Han","year":"2017","unstructured":"Han DX, Sun XL, Xu MQ, Chen CZ, Jiang H, Gao Y, Yuan B, Zhang JB (2017) Roles of differential expression of microRNA-21-3p and microRNA-433 in FSH regulation in rat anterior pituitary cells. Oncotarget 8(22):36553\u201336565. https:\/\/doi.org\/10.18632\/oncotarget.16615","journal-title":"Oncotarget"},{"key":"4890_CR64","doi-asserted-by":"publisher","first-page":"111080","DOI":"10.1016\/j.exger.2020.111080","volume":"141","author":"R Wang","year":"2020","unstructured":"Wang R, Zhang J (2020) Clinical significance of miR-433 in the diagnosis of Alzheimer\u2019s disease and its effect on Abeta-induced neurotoxicity by regulating JAK2. Exp Gerontol 141:111080. https:\/\/doi.org\/10.1016\/j.exger.2020.111080","journal-title":"Exp Gerontol"},{"issue":"7","key":"4890_CR65","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1007\/s11011-022-01015-3","volume":"37","author":"D Tong","year":"2022","unstructured":"Tong D, Zhao Y, Tang Y, Ma J, Wang M, Li B, Wang Z, Li C (2022) MiR-487b suppressed inflammation and neuronal apoptosis in spinal cord injury by targeted Ifitm3. Metab Brain Dis 37(7):2405\u20132415. https:\/\/doi.org\/10.1007\/s11011-022-01015-3","journal-title":"Metab Brain Dis"},{"issue":"3","key":"4890_CR66","doi-asserted-by":"publisher","first-page":"7785","DOI":"10.1080\/21655979.2022.2048995","volume":"13","author":"H Wang","year":"2022","unstructured":"Wang H, Zeng Z, Yi R, Luo J, Chen J, Lou J (2022) MicroRNA-3200-3p targeting CAMK2A modulates the proliferation and metastasis of glioma in vitro. Bioengineered 13(3):7785\u20137797. https:\/\/doi.org\/10.1080\/21655979.2022.2048995","journal-title":"Bioengineered"},{"key":"4890_CR67","doi-asserted-by":"publisher","first-page":"530134","DOI":"10.1155\/2014\/530134","volume":"2014","author":"A Zada","year":"2014","unstructured":"Zada A, Mundhofir FE, Pfundt R, Leijsten N, Nillesen W, Faradz SM, de Leeuw N (2014) A rare, recurrent, De Novo 14q32.2q32.31 microdeletion of 1.1 Mb in a 20-year-old female patient with a maternal UPD(14)-like phenotype and intellectual disability. Case Rep Genet 2014:530134. https:\/\/doi.org\/10.1155\/2014\/530134","journal-title":"Case Rep Genet"},{"issue":"1","key":"4890_CR68","doi-asserted-by":"publisher","first-page":"15787","DOI":"10.1038\/s41598-019-51948-6","volume":"9","author":"GN Valbuena","year":"2019","unstructured":"Valbuena GN, Apostolidou S, Roberts R, Barnes J, Alderton W, Harper L, Jacobs I, Menon U, Keun HC (2019) The 14q32 maternally imprinted locus is a major source of longitudinally stable circulating microRNAs as measured by small RNA sequencing. Sci Rep 9(1):15787. https:\/\/doi.org\/10.1038\/s41598-019-51948-6","journal-title":"Sci Rep"},{"issue":"1","key":"4890_CR69","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/ng882","volume":"31","author":"T Mantamadiotis","year":"2002","unstructured":"Mantamadiotis T, Lemberger T, Bleckmann SC, Kern H, Kretz O, Martin Villalba A, Tronche F, Kellendonk C, Gau D, Kapfhammer J, Otto C, Schmid W, Schutz G (2002) Disruption of CREB function in brain leads to neurodegeneration. Nat Genet 31(1):47\u201354. https:\/\/doi.org\/10.1038\/ng882","journal-title":"Nat Genet"},{"issue":"46","key":"4890_CR70","doi-asserted-by":"publisher","first-page":"10747","DOI":"10.1523\/JNEUROSCI.2662-05.2005","volume":"25","author":"A Paquin","year":"2005","unstructured":"Paquin A, Barnabe-Heider F, Kageyama R, Miller FD (2005) CCAAT\/enhancer-binding protein phosphorylation biases cortical precursors to generate neurons rather than astrocytes in vivo. J Neurosci 25(46):10747\u201310758. https:\/\/doi.org\/10.1523\/JNEUROSCI.2662-05.2005","journal-title":"J Neurosci"},{"key":"4890_CR71","doi-asserted-by":"publisher","first-page":"21534","DOI":"10.1038\/srep21534","volume":"6","author":"B Liu","year":"2016","unstructured":"Liu B, Ma A, Zhang F, Wang Y, Li Z, Li Q, Xu Z, Zheng Y (2016) MAZ mediates the cross-talk between CT-1 and NOTCH1 signaling during gliogenesis. Sci Rep 6:21534. https:\/\/doi.org\/10.1038\/srep21534","journal-title":"Sci Rep"},{"issue":"5","key":"4890_CR72","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nm1747","volume":"14","author":"JH Kordower","year":"2008","unstructured":"Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW (2008) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease. Nat Med 14(5):504\u2013506. https:\/\/doi.org\/10.1038\/nm1747","journal-title":"Nat Med"},{"issue":"1","key":"4890_CR73","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40478-020-0894-0","volume":"8","author":"C McKinnon","year":"2020","unstructured":"McKinnon C, De Snoo ML, Gondard E, Neudorfer C, Chau H, Ngana SG, O\u2019Hara DM, Brotchie JM, Koprich JB, Lozano AM, Kalia LV, Kalia SK (2020) Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by alpha-synuclein. Acta Neuropathol Commun 8(1):17. https:\/\/doi.org\/10.1186\/s40478-020-0894-0","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"4890_CR74","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s12035-014-8639-3","volume":"50","author":"SV Hegarty","year":"2014","unstructured":"Hegarty SV, Sullivan AM, O\u2019Keeffe GW (2014) Roles for the TGFbeta superfamily in the development and survival of midbrain dopaminergic neurons. Mol Neurobiol 50(2):559\u2013573. https:\/\/doi.org\/10.1007\/s12035-014-8639-3","journal-title":"Mol Neurobiol"},{"issue":"1","key":"4890_CR75","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/jmcb\/mjt043","volume":"6","author":"M Joksimovic","year":"2014","unstructured":"Joksimovic M, Awatramani R (2014) Wnt\/beta-catenin signaling in midbrain dopaminergic neuron specification and neurogenesis. J Mol Cell Biol 6(1):27\u201333. https:\/\/doi.org\/10.1093\/jmcb\/mjt043","journal-title":"J Mol Cell Biol"},{"issue":"1","key":"4890_CR76","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13024-017-0153-4","volume":"12","author":"DC Berwick","year":"2017","unstructured":"Berwick DC, Javaheri B, Wetzel A, Hopkinson M, Nixon-Abell J, Granno S, Pitsillides AA, Harvey K (2017) Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of beta-catenin signaling. Mol Neurodegener 12(1):9. https:\/\/doi.org\/10.1186\/s13024-017-0153-4","journal-title":"Mol Neurodegener"},{"issue":"8","key":"4890_CR77","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1002\/stem.1708","volume":"32","author":"F L'Episcopo","year":"2014","unstructured":"L\u2019Episcopo F, Tirolo C, Testa N, Caniglia S, Morale MC, Serapide MF, Pluchino S, Marchetti B (2014) Wnt\/beta-catenin signaling is required to rescue midbrain dopaminergic progenitors and promote neurorepair in ageing mouse model of Parkinson\u2019s disease. Stem Cells 32(8):2147\u20132163. https:\/\/doi.org\/10.1002\/stem.1708","journal-title":"Stem Cells"},{"key":"4890_CR78","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/bs.ctdb.2017.10.002","volume":"127","author":"EE Santo","year":"2018","unstructured":"Santo EE, Paik J (2018) FOXO in neural cells and diseases of the nervous system. Curr Top Dev Biol 127:105\u2013118. https:\/\/doi.org\/10.1016\/bs.ctdb.2017.10.002","journal-title":"Curr Top Dev Biol"},{"issue":"6","key":"4890_CR79","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1093\/hmg\/ddt530","volume":"23","author":"E Pino","year":"2014","unstructured":"Pino E, Amamoto R, Zheng L, Cacquevel M, Sarria JC, Knott GW, Schneider BL (2014) FOXO3 determines the accumulation of alpha-synuclein and controls the fate of dopaminergic neurons in the substantia nigra. Hum Mol Genet 23(6):1435\u20131452. https:\/\/doi.org\/10.1093\/hmg\/ddt530","journal-title":"Hum Mol Genet"},{"key":"4890_CR80","doi-asserted-by":"publisher","first-page":"114619","DOI":"10.1016\/j.biopha.2023.114619","volume":"162","author":"X Wei","year":"2023","unstructured":"Wei X, Huang G, Liu J, Ge J, Zhang W, Mei Z (2023) An update on the role of Hippo signaling pathway in ischemia-associated central nervous system diseases. Biomed Pharmacother 162:114619. https:\/\/doi.org\/10.1016\/j.biopha.2023.114619","journal-title":"Biomed Pharmacother"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04890-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-04890-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04890-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T09:01:43Z","timestamp":1757149303000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-04890-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":80,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["4890"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-04890-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,4]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SR is currently employed by ECONCARE, SA, Athens, Greece. The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}